Simple high-performance liquid chromatographic method to monitor vigabatrin, and preliminary review of concentrations determined in epileptic patients

Annals of Clinical Biochemistry

Volumn 37, Issue 3, 2000, Pages 338-342

  George, S ^a   Gill, L ^a   Braithwaite, R A ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; EPILEPSY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY CONTROL; STANDARD;

EID: 0034054550     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563001899249     Document Type: Article

References (11)

1. Grant SM, Heel RC. Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 1991; 41: 889-926
2. Chadwick D. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Lancet 1999; 354: 13-9
3. Jacqz-Aigrain E, Guillonneau M, Rey E, Macher MA, Montes C, Chiron C, et al. Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chromic dosing in a patient with renal failure. Br J Clin Pharmacol 1997; 44: 183-5
4. Rey E, Pons G, Olive G. Vigabatrin clinical pharmacokinetics. Clin Pharmacokin 1992; 23: 267-78
5. Gatti G, Bartoli A, Marchiselli R, Michelucci R, Tassinari CA, Pisani F, et al. Vigabatrin-induced decrease in serum phenytoin concentration dose not involve a change in phenytoin bioavailability. Br J Clin Pharmacol 1993; 36: 603-6
6. Rey E, Pons G, Richard MO, Vauzelle F, D'Athis PH, Chiron C, et al. Pharmacokinetics of the individual enantiomers of vigabatrin (γ-vinyl GABA) in epileptic children. Br J Clin Pharmacol 1990; 30: 253-7
7. Edelbroek PM, Vermeij AC. Pharmacokinetics of vigabatrin enantiomers by new h.p.l.c. method using a simple precolumn derivatization with OPA/N-acetyl-L-cysteine. Br J Clin Pharmacol 1998; 46: 627P
8. Ratnaraj N, Patsalos PN. A high performance liquid chromatography micromethod for the simultaneous determination of vigabatrin and gabapentin in scrum. Ther Drug Monit 1998; 20: 430-4
9. Berry D. Monitoring newer antiepileptic drugs. Syva Drug Monitor 1997; 2.10: 5-6
10. Bates DW. Improving the use of therapeutic drug monitoring. Ther Drug Monit 1998; 20: 550-5
11. George S, Wood AJ, Braithwaite RA. Routine therapeutic monitoring of lamotrigine in epileptic patients using a simple and rapid high performance liquid chromatographic technique. Ann Clin Biochem 1995; 32: 584-8